Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / This research aims to verify the hearing condition of goers of support groups for former drug users. It was evaluated 17 individuals, all former drug users, being marijuana, crack and cocaine the most used drugs. The individuals were divided into two groups according to the kind of the most commonly used drug: Group 1 (G1) - 10 former users of marijuana, Group 2 (G2) - Seven former users of crack/cocaine. For the results analysis, they were also subdivided according to the time of drug use: one to five years, six to 10 years and more than 15 years. The subjects were submitted to anamnesis, pure tone audiometry (PTA), acoustic impedance measurements, transient evoked otoacoustic emissions (TEOAE), suppressive effect of TEOAE and brainstem evoked response audiometry (BERA). By comparing the results of PTA of the G1 and G2 with one to five years of drug use, G2 presented pure tone levels greater than 25 dB with a significant statistically difference in the pure tone levels for the frequencies of 250, 500, 6000 and 8000 Hz in the right ear. In the group of six to 10 years of drug use it was not found significant difference in pure tone levels for frequencies of 4000 and 8000 Hz in the left ear, with worse pure tone levels for the G2. For the group with more than 15 years of drug use, it was observed pure tone levels above 25 dB for the frequencies from 3000 to 8000 Hz in the right ear. In evaluations with TEOAE, TEOAE suppression effect and BERA, it was not observed a difference in the results when they were compared according to the time of drug use. G1 presented an average in the relation signal/noise of TEOAE greater than the average in the G2, but without a significant statistically difference. The two groups did not differ in the occurrence of suppressor effect of TEOAE and absolute latency and inter-peak interval of BERA. It is emphasized that only five individuals had adequate results for the age group in the BERA. As the time of drug use increases, more changes were observed in the G1 results in PTA and BERA, but it did not interfere in the results of the evaluations of the G2. The results suggest that the use of drugs can cause peripheral and central hearing loss, and that the use of crack/cocaine is more deleterious to the hearing that the use of marijuana. / O presente trabalho tem como objetivo verificar a condição auditiva de frequentadores de grupos de apoio a ex-usuários de drogas. Foram avaliados 17 indivíduos ex-usuários de drogas, estando entre as mais usadas a maconha, o crack e a cocaína. Os indivíduos foram divididos em dois grupos, conforme o tipo de droga mais consumida: Grupo 1 (G1) 10 ex-usuários de maconha; Grupo 2 (G2) sete ex-usuários de crack/cocaína. Para a análise dos resultados, houve uma subdivisão conforme o tempo de uso de drogas: um a cinco anos, seis a 10 anos e mais do que 15 anos. Os indivíduos foram submetidos à anamnese, audiometria tonal liminar (ATL), medidas de imitância acústica, emissões otoacústicas transientes (EOAT), efeito supressor das EOAT e potenciais evocados auditivos de tronco encefálico (PEATE). Ao comparar os resultados da ATL do G1 e G2 com um a cinco anos de uso de drogas, o G2 apresentou limiares tonais maiores que 25 dBNA com diferença estatisticamente significante nos limiares tonais para as frequências de 250, 500, 6000 e 8000 Hz na orelha direita. No grupo de seis a 10 anos de uso de drogas houve diferença estatisticamente significante nos limiares tonais para as frequências de 4000 e 8000 Hz da orelha esquerda, com limiares piores para o G2. Para o grupo com mais de 15 anos de uso de drogas, observou-se limiares tonais acima de 25 dBNA para as frequências de 3000 a 8000 Hz na orelha direita. Nas avaliações com EOAT, efeito supressor das EOAT e PEATE não se observou diferença nos resultados quando foram comparados conforme o tempo de uso de drogas. O G1 apresentou média da relação sinal/ruído das EOAT superior ao G2, porém sem diferença estatisticamente significante. Os dois grupos não diferiram quanto à ocorrência do efeito supressor das EOAT, bem como quanto às latências absolutas e aos intervalos interpicos do PEATE. Ressalta-se que apenas cinco indivíduos apresentaram resultados adequados para a faixa etária no PEATE. O tempo de uso da droga exerceu influência nos resultados do G1 na ATL e PEATE; observou-se que quanto maior o tempo, maiores as alterações. Porém, o tempo de uso não interferiu nos resultados das avaliações do G2. Os resultados encontrados sugerem que o uso de drogas pode provocar alterações auditivas periféricas e centrais, e que o uso de crack/cocaína é mais deletério para a audição que o uso de maconha.

Objetivos: avaliar a prevalência de alterações auditivas em recém-nascidos de muito baixo peso na Unidade de Tratamento Intensivo Neonatal do Hospital de Clínicas de Porto Alegre e estudar as variáveis que possam estar relacionadas com as alterações da acui-dade auditiva. Métodos: foi realizado um estudo transversal que incluiu todos os recém-nascidos de muito baixo peso admitidos na Unidade de Tratamento Intensivo Neonatal do Hospital de Clínicas de Porto Alegre no período de 1o de setembro de 2001 a 31 de janeiro de 2002. To-dos os pacientes foram submetidos ao exame de otoemissão acústica evocada por produto de distorção no momento da alta hospitalar. O exame foi repetido em 30 dias quando havia alte-ração no primeiro exame. Quando o paciente apresentava o exame de otoemissão acústica al-terada em duas ocasiões, era realizado o potencial auditivo evocado cerebral, considerado al-terado a partir de 35 dB NA. Resultados: foram estudados 96 recém-nascidos. Seis tiveram tanto o exame de otoemissão acústica quanto o potencial auditivo evocado cerebral alterados. A média da idade gestacional foi de 31,5 ± 2,6 semanas, o peso de nascimento variou de 640 a 1.500 g e 57,3% dos pacientes eram do sexo feminino. A idade gestacional e o índice de Apgar no 5o minuto foram inferiores no grupo otoemissão acústica e potencial auditivo evocado cerebral alterados em relação aos demais grupos, atingindo significância limítrofe. Conclusões: a prevalência de perda auditiva nos recém-nascidos de muito baixo peso da Unidade de Tratamento Intensivo Neonatal do Hospital de Clínicas de Porto Alegre foi de 6,3%, tendo sido observadas associações de significância limítrofe com idade gestacional e índice de Apgar no 5o minuto. / Objectives: to evaluate the prevalence of hearing loss in very low birth weight patients in the Neonatal Intensive Care Unit of the Hospital de Clínicas de Porto Alegre and to study the variables that can be related to hearing loss. Methods: a transversal study was carried through including all very low birth weight neonates admitted in the Neonatal Intensive Care Unit of the Hospital de Clínicas de Porto Alegre during September 1, 2000 to January 31, 2002. All patients were undergone to the distortion evoked otoacoustic emission test in the hospital discharge. When the patient presented alteration in this test, it was repeated in 30 days. However, when the patient who presented pathologic otoacoustic emission on two ocasions was undergone to the auditory evoked brain response. This test was considered abnormal from 35 dB NA. Results: we studied 96 neonates. Six children presented alteration in the distortion evoked otoacoustic emission test as well in the auditory evoked brain response. The children age average was 31.5 ± 2.6 weeks, their birth weight was between 640 g and 1,500 g, and 57.3% of the patients were female. The gestational age and the Apgar score at 5 minutes were inferior in the otoacoustic emission and auditory evoked brain response abnormal group related to the other groups, reaching bordering significance. Conclusions: the hearing loss prevalence of the very low birth weight neonates from the Neonatal Intensive Care Unit of the HCPA was 6.3%, and it was observed bordering significance associations related to gestational age and 5 minutes Apgar score.

Com o objetivo de analisar o efeito de supressão das emissões otoacústicas transientes com a apresentação de ruído branco contralateral, foram avaliadas 51 crianças de 7 a 11 anos, sendo 15 sem queixas auditivas (grupo controle) e 36 com distúrbio de processamento auditivo (divididas em dois grupos experimentais). Foram determinados, para cada grupo, a média e o desvio padrão dos valores de supressão em cada condição de estímulo: clique linear e clique não linear. Verificou-se que a proporção de ausência do efeito de supressão foi significativamente maior nos grupos de crianças com distúrbio de processamento auditivo, comparados ao grupo controle / This study concerns the suppression of transient evoked otoacoustic emissions by contralateral white noise in children with auditory processing disorder. Fifty-one children between 7 and 11 years old were assessed, being 15 children without auditory complaints (control group) and 36 with auditory processing disorder (divided in two experimental groups). The mean suppression of otoacoustic emissions and standard deviation were determined for each group, both in linear and nonlinear acquisition mode. The results provided evidence that proportion of absence of otoacoustic emissions suppression was significantly higher in auditory processing disorder groups, when compared to control group

Apart from isolated programs in private and public health care sectors, South Africa has no existing systematic public infant hearing screening program at community level. As a result, early identification of hearing loss is certainly not being attained for the majority of infants in South Africa with far-reaching effects for individuals, families and society at large. Screening programs at primary health care immunization clinics have been proposed as an alternative to hospital-based programs in South Africa. The objective of this study was to evaluate the first systematic community-based infant hearing screening program in a developing South African community in the Western Cape. A combined descriptive and exploratory research methodology was followed incorporating aspects of a program evaluation design. The study was of a quantitative nature and the required data were collected by means of a questionnaire and OAE testing conducted by clinic nurses on subjects. A community-based universal infant hearing screening program initiated at eight primary health care clinics in the Cape Metropolitan area was evaluated over a 19-month research period. During this time 6227 infants who were candidates for screening attended their 6, 10 or 14-week immunization visit at the relevant clinic. Clinic nurses were trained as screening personnel. A two-stage distortion product otoacoustic emissions screening protocol was utilized. The target disorder for this study was bilateral permanent congenital and early onset hearing loss and infants referring the first screen were scheduled for a 4-week follow-up visit at the clinic. Diagnostic audiological and medical evaluations were scheduled at referral hospitals when indicated. The study evaluated the efficacy of the program based on coverage, referral and follow-up rates and diagnostic outcomes according to guidelines specified by the Health Professions Council of South Africa 2007 Position Statement. Overall coverage rate across the eight clinics was 32.4% with 2018 infants (aged 0- 14 weeks) screened. The mean age of the sample at first stage screen was 3.9 weeks of age and 13.5 weeks of age for first hospital visit. Overall first stage screen referral rate was 9.5% with 62 subjects (3%) referred for diagnostic services at hospital level after a follow-up screen. The average follow-up rate for rescreens at clinic level was 85.1% and for initial diagnostic assessments at hospital level it was 91.8%. Although minimal hearing loss was not the primary focus of the screening program the outcomes did include those subjects with fluctuating conductive hearing loss and permanent unilateral hearing loss. Prevalence rates were 4.5/1000 with significant hearing loss, including sensorineural (1.5/1000) and conductive (3/1000) losses, and 12.9/1000 for subjects with middle ear effusion.<p-> The community-based infant hearing screening program was valuable in attaining high follow-up return rates but reaching sufficient coverage may require dedicated screening personnel as opposed to existing nursing personnel. Furthermore, consideration of an alternative community-based platform such as midwife obstetric units may improve coverage and referral rates and prevalence of permanent congenital and early onset hearing loss. / Dissertation (MCommunication Pathology)--University of Pretoria, 2013. / Speech-Language Pathology and Audiology / Unrestricted

Le système auditif ascendant est constitué d’étages multiples procédant chacun à un traitement complexe du signal, traitement qui est modulé par un système descendant, formant de multiples boucles corticales et sous-corticales de rétroaction : le système efférent auditif. La boucle la plus longue de ce système serait capable de moduler directement le fonctionnement des cellules sensorielles de l’organe périphérique de l’audition. Le but de ce travail était d’étudier pour la première fois chez le sujet sain, l’effet d’une modulation corticale expérimentale sur le fonctionnement périphérique auditif. Nous avons donc recueilli, dans le cadre d’un protocole en double aveugle contre placebo, chez 34 sujets sains, l’activité des cellules ciliées externes de l’organe de Corti (cellules sensorielles directement en contact avec les fibres nerveuses efférentes), par le recueil d’otoémissions acoustiques (OEAs), avant et après stimulation du cortex auditif par une stimulation magnétique transcrânienne répétitive (SMTr). Une diminution de l’amplitude d’un type d’OEA a été obtenue du côté controlatéral à une stimulation du cortex auditif par SMTr à 10 Hz, effet qui ne peut être expliqué seulement par une action non-spécifique liée au bruit de la SMTr mais qui reste extrêmement variable d’un sujet à un autre. De plus, nous avons montré, du côté ipsilatéral à la SMTr, une diminution de l’amplitude des OEAs immédiatement après la SMTr, et uniquement pour les fortes intensités d’utilisation de la SMTr (donc, pour des niveaux de bruit plus importants), reflétant un effet direct du bruit de la SMTr sur les mécanismes cochléaires actifs, effet présent chez nos sujets même en cas de protections auditives de bonne qualité / The ascending auditory system involves multiples stages where the auditory information is processed and modulated by a top-down influence involving multiple cortico sub-cortical loops: the efferent auditory system. It is hypothesized that the longest loop of this efferent system is able to modulate directly the sensory cells of the peripheral auditory organ. The aim of this work was to study this system, to our knowledge for the first time in healthy humans, and to show a direct cortical influence on the auditory periphery. In a double blind randomized procedure, we recorded, in 34 healthy subjects, the activity of outer hair cells of the organ of Corti (sensory cells, that are in direct synaptic contact with medial efferent fibers), by means of evoked otoacoustic emissions (OAEs), before and after auditory cortex stimulation by repetitive transcranial magnetic stimulation (rTMS). We showed an inhibitory influence of the auditory cortical stimulation by 10 Hz rTMS on OAE amplitudes, predominantly in the ear contralateral to the rTMS, effect that cannot be attributed to a non-specific effect linked to the impulse noise associated with the rTMS technique, but that remains highly variable across subjects. In addition, we showed a decrease in OAE amplitude on the ipsilateral side, immediately after the rTMS session and only for high rTMS intensities (and hence, higher noise levels), that reflect a direct influence of the rTMS noise on the auditory periphery, effect that is present even in well ear-protected subjects

Infant hearing screening (IHS) programs are not yet widespread in developing countries, such as South Africa. In order to ensure that the benefits of early hearing detection and intervention (EHDI) programs reach all infants, initial recommendations for the implementation of IHS programs in South Africa have been made by the Year 2002 Hearing Screening Position Statement by the Health Professions Council of South Africa. One of the platforms recommended for IHS in South Africa is the neonatal intensive care unit (NICU). South African NICU infants are at an increased risk for hearing loss, resultant of their high-risk birth histories, as well as the prevalence of context-specific environmental risk factors for hearing loss. There is currently a general scarcity of contextual data regarding the prevalence of risk indicators for hearing loss, and the prevalence of auditory impairment in the South African NICU population. The objective of this study was to describe an IHS program for NICU infants at a secondary hospital in Gauteng, South Africa. A quantitative descriptive research design was used to report on a cohort of 129 NICU infants followed up during a 29 month period. The objective of the study was achieved by describing the sample of infants in terms of the presence of specific risk indicators for hearing loss, the efficiency of the IHS program, and the incidence of auditory pathologies. Infants received their initial hearing screening as part of their medical and developmental follow-up visit at the hospital at three months of age. Routine rescreening visits were scheduled three monthly, whilst infants who failed the hearing screening were requested to return after three weeks for a follow-up. A data collection sheet was used to collect biographical information and risk indicators for hearing loss. Immittance measurements were recorded in the form of high-frequency and low-frequency tympanometry. Distortion product otoacoustic emissions (DPOAE) and automated auditory brainstem responses (AABR) were recorded, as well as diagnostic auditory brainstem responses (ABR) in cases where infants referred the screening protocol. Results revealed that environmental risk factors present in this sample included poor maternal education levels and prenatal HIV/AIDS exposure. At least 32% of mothers participating in this study did not complete high school. Prenatal HIV/AIDS exposure was present in at least 21% of the current sample of infants. The screening coverage rate fell short of the 95% benchmark set by the Joint Committee on Infant Hearing (JCIH, 2000). A 67% coverage rate was achieved with AABR screening, and an 88% coverage rate was achieved with DPOAE screening. 93% of infants had immittance screening performed on their initial visit to the IHS program. According to the Fisher’s two-sided exact test and the logistic regression procedure, high frequency tympanometry proved to be more effective than low frequency tympanometry, when assessing the middle ear functioning of infants younger than seven months when compared with DPOAE results. Normative pressure and admittance data was compiled for the use of high frequency tympanometry in NICU infants. Poor follow-up rates were recorded for both routine and non-routine visits, but are expected to improve over time. Furthermore, results indicated a high incidence of hearing impairment. Permanent congenital hearing loss was identified in 3% (n=4) of the sample. Half of these presented with sensorineural hearing loss, whilst the other half had auditory neuropathy. The incidence of auditory impairment is estimated to be 3.75% if the percentage of infants who did not return for follow-up is taken into account. A high incidence of middle ear pathology was recorded, with an incidence rate of 60.4%, including bilateral and unilateral middle ear pathology. The high prevalence of auditory impairment in South African NICU infants, and the lack of widespread IHS programs, indicates that many vulnerable infants are being the denied the benefits of early identification of and intervention for hearing loss. The implementation of widespread IHS programs in South Africa is therefore essential, in order to ensure that all South African infants receive the benefits of EHDI programs. / Dissertation (MCommunication Pathology)--University of Pretoria, 2007. / Speech-Language Pathology and Audiology / unrestricted

L’imagerie par résonance magnétique (IRM) est l’une des techniques les plus utilisées en neurosciences. Malheureusement, elle implique une exposition à des niveaux de bruit importants. Cette exposition peut entraîner des effets temporaires ou permanents sur l’audition, surtout lorsqu’elle est prolongée ou répétée. Plusieurs inconnus subsistent au sujet des risques pour l’audition de sujets subissant des examens en IRM à répétition. L’objectif de ce projet était de suivre six participants de recherche subissant des examens IRM hebdomadaires et d’évaluer sur une base régulière l’évolution de leur audition. L’audition des participants a été testée périodiquement sur une période d’un an et demi. Des valeurs de référence ont été récoltées pour chacun des tests avant le début de ce projet. Des séances de tests auditifs ont ensuite été planifiées immédiatement avant et après un scan ainsi qu’à la suite d’un délai variant entre deux et sept jours après un scan. Un article scientifique présentant les résultats les plus importants de ce projet a été rédigé. Il comporte les résultats à deux des tests administrés aux participants: l’audiométrie par tons purs et les émissions otoacoustiques par produit de distorsion. Aucun effet de l’exposition au bruit du scanneur n’a été révélé par ces tests. / Magnetic resonance imaging (MRI) is one of the most commonly used tools in neuroscience. However, it implies exposure to high noise levels. It is well known that exposure to noise can lead to temporary or permanent hearing damages, especially when the exposure is long or repeated. Little is known about the hearing risks of people undergoing several MRI examinations, especially in the context of prolonged longitudinal studies. The goal of this research project was to follow six research participants undergoing weekly MRI scan sessions and test the evolution of their auditory health on a regular basis. The participants’ hearing was tested periodically, over a period of a year-and-a-half. First, baseline values were acquired for each of the hearing tests before the beginning of this research project. Hearing tests were then scheduled immediately before/after a scan and with a delay between two and seven days after a scan. A scientific publication was written outlying the main results regarding two of the administered tests: pure-tone audiometry and distortion product otoacoustic emissions. No consistent impacts of the scanner noise exposure were found for those two tests.

No description available.

INTRODUÇÃO: Os aminoglicosídeos são freqüentemente usados no berçário e podem ser tóxicos para as células ciliadas cócleo-vestibulares, especialmente para as células ciliadas externas da base da cóclea. As emissões ototacústicas produto de distorção permitem avaliar porções específicas da cóclea, antes mesmo que a sensação auditiva seja alterada, sendo ideais para análise precoce da integridade dessa estrutura auditiva, além de ser indicada para recém-nascidos por serem objetivas. O objetivo deste estudo prospectivo longitudinal é pesquisar a amplitude das emissões otoacústicas produto de distorção, causadas pelo uso de drogas ototóxicas, entre o término da administração e de 15 a 40 dias após seu uso. MÉTODOS: A população foi de recém-nascidos a termo e pré-termo provenientes de berçário e maternidade de um hospital público em Santo André, no período de julho de 2003 a setembro de 2004. A primeira avaliação ocorreu no dia da alta hospitalar. Foram avaliados três grupos: grupo controle com 33 recém-nascidos saudáveis e de termo; grupo de estudo a termo exposto a amicacina e /ou vancomicina com 19 recém-nascidos com mais de 37 semanas e grupo de estudo pré-termo exposto aos mesmos ototóxicos, com 15 recém-nascidos de 32 a 37 semanas. Os recém-nascidos não apresentavam indicadores de risco para deficiência auditiva preconizados pelo JCIH,2000 concomitante à infecção neonatal. Todos os recém-nascidos foram avaliados com idade gestacional corrigida maior que 37 semanas. As amplitudes das emissões otoacústicas dos recém-nascidos em fase de alta hospitalar foram comparadas às obtidas de 15 a 40 dias após a alta. RESULTADOS: As amplitudes das emissões otoacústicas dos recém-nascidos do grupo de estudo pré-termo foram menores que as amplitudes do grupo controle e do grupo de estudo a termo nos dois momentos de teste. As amplitudes das emissões dos recém-nascidos dos três grupos aumentaram no segundo momento de teste. As amplitudes das emissões dos recém-nascidos foram maiores na freqüência de 6.000 Hz e na orelha direita para a freqüência f2 3.000 Hz. As amplitude das emissões do grupo controle no segundo momento de teste foram semelhantes as do grupo de estudo à termo no primeiro momento da pesquisa. CONCLUSÔES: Houve aumento da amplitude das emissões otoacústicas produto de distorção desde a fase de alta até 15 a 40 dias após. A exposição a amicacina e vancomicina nas doses preconizadas pelo Neofax®, 2003/2004 não alterou as amplitudes das emissões nos recém-nascidos sem indicadores de risco concomitante à infecção neonatal. / The amynoglicosides are frequently used in nurseries and may be toxic for the cochleo-vestibular hair cells, specially for the outer cells of the cochlear base. The distortion product otoacoustic emissions allow to evaluate specific portions of the cochlea even before the hearing sensation is altered, and are ideal for the early analysis of this auditory structure integrity, besides being indicated for newborns once they are objective. The aim of this prospective longitudinal study is to research the amplitude of distortion product otoacoustic emissions caused by the ototoxic drugs use, between the end of the administration and from 15 to 40 days after its use. The population studied was composed by term and preterm newborns from a nursery and maternity of a Santo André city hospital, in the period from July 2003 to September 2004. The first evaluation occurred on the hospital discharge day. Three groups were evaluated: control group with 33 term and healthy newborns; term study group with 19 term newborns with more than 37 weeks exposed to amicacin and/or vancomycin; and preterm study group with 15 preterm newborns from 32 to 37 weeks exposed to the same ototoxic. The newborns did not present risk factors for hearing loss according to the JCIH, 2000 concomitant to the neonatal infection. All newborns were evaluated at a corrected gestational age greater than 37 weeks. The otoacoustic emissions amplitudes obtained at the hospital discharge were compared to the ones obtained from 15 to 40 days after the discharge. The results showed that the otoacoustic emissions amplitudes of the preterm study group were smaller than the amplitudes of the control group and the term study group in both moments of the test. The amplitude of the newborns’ otoacoustic emissions increased in the second moment of the test. The amplitudes were higher in the frequency of 6.000Hz and, in the right ear in the frequency f2 3.000 Hz. The otoacoustic emissions amplitudes of the control group in the second moment of the test were similar to the term study group in the first moment of the research. It was concluded that there is an increase of the distortion product otoacoustic emissions amplitude from the discharge moment until 15 to 40 days after, suggesting a maturation of the cochlear structures in the post-natal period, and that the exposure to amicacin and vancomycin on the recommended dose by Neofax®, 2003/2004 did not alter the amplitude of the emissions in the newborns without risk indicators concomitant with neonatal infection.

Ein tieffrequenter lauter Suppressorton verlagert das Corti-Organ periodisch in Richtung Scala vestibuli und Scala tympani. Simultan registrierte DPOAE (Distorsionsprodukte otoakustischer Emissionen) werden in beiden Richtungen unterschiedlich supprimiert. Bei Vorliegen eines endolymphatischen Hydrops (EH) ist die Beweglichkeit der Basilarmembran eingeschränkt, so daß keine oder eine nur geringe Modulation des DPOAE-Pegels entstehen kann. In dieser Arbeit wird die diagnostische Aussagekraft von Messungen tieftonmodulierter DPOAE bei zwei Patientenkollektiven mit Verdacht auf EH im Vergleich mit einem Normalkollektiv (n = 22) geprüft: bei Patienten mit M. Menière (n = 23) und Patienten mit Ohrdruckgefühl ohne Schwindelsymptomatik (n = 8). Bei den M. Menière-Patienten sind die ipsilateralen Modulationstiefen (MD) im Median hochsignifikant geringer als die des Normalkollektivs. Dies wird als Hinweis auf einen EH gewertet. Bei Primärtonpegeln mit L2 = 20 dB SL ergibt sich für den Grenzwert der MD mit 6 dB die Sensitivität von 64% und die Spezifität von 90%. Die kontralateralen MD der M. Menière-Patienten sind im Median signifikant geringer als die des Normalkollektivs. Für Primärtonpegel mit L2 = 20 dB SL liegen 33% der Werte unter dem Grenzwert, von diesen Ohren ist die Hälfte symptomfrei. Auch im kontralateralen Ohr kann ein – eventuell asymptomatischer – Hydrops vorliegen. Die Ergebnisse der Patienten mit Ohrdruckgefühl ohne Schwindel zeigen im Median hochsignifikant geringere MD als die der Normalhörenden und unterscheiden sich nicht signifikant von den Werten der ipsilateralen Ohren der M. Menière-Patienten. Das Ohrdruckgefühl kann auf einen cochleären Hydrops hinweisen und die weitere Entwicklung eines EH ankündigen. Bei den Verlaufsuntersuchungen zeigen die MD beider Patientenkollektive, deren Symptomatik sich während dieses Zeitraums änderte, Variabilitäten: mit Zunahme der Heftigkeit der spezifischen Symptome nimmt die MD ab und umgekehrt. Die Tieftonmodulation scheint den Zustand der Cochlea widerspiegeln zu können. Im Vergleich mit den in der Klinik gängigen Verfahren zur Hydropsdiagnostik wie der ECochG oder dem Glyceroltest erweist sich das in dieser Arbeit angewandte objektive Verfahren als vorteilhaft: es ist schnell durchführbar, nicht belastend und nicht invasiv. Es eignet sich als Screeningverfahren und kann zur Verlaufskontrolle eingesetzt werden. / The cochlear partition is moved periodically towards scala vestibuli and scala tympani by a low-frequency high-level suppressor tone. Simultaneously recorded DPOAEs (distortion product otoacoustic emissions) are suppressed differently in both directions. This modulation of the DPOAE level may be reduced or even missing if the displacement of the basilar membrane is inhibited by endolymphatic hydrops (EH). In this thesis the diagnostic significance of the low-frequency modulation of DPOAEs is tested in two patient groups with suspected EH: patients with Menière’s disease (n = 23) and patients with aural fullness without vertigo (n = 8), compared to a control group of normal hearing adults (n = 22). In the patients with Menière’s disease the ipsilateral modulation depths (median) are high significantly lower than in the control group. This can be interpreted as a sign of EH. At primary tone levels with L2 = 20 dB SL and a limiting value of 6 dB modulation depth (MD), a sensitivity of 64% and a specificity of 90% are found. The contralateral MDs of the patients with Menière’s disease (median) are significantly lower than in the control group. At primary tone levels with L2 = 20 dB SL, 33% of the MDs are below the limiting value, half of these ears are symptom-free. So in the contralateral ear a possibly asymptomatic hydrops may be present as well. The patients with aural fullness without vertigo show high significantly lower MDs (median) than the normal hearing adults and no significant difference to the ipsilateral MDs of the patients with Menière’s disease. Aural fullness can be a sign of cochlear hydrops and may indicate the further development of EH. During the course of disease the MDs of both patient groups vary when symptoms change: with increasing intensity of the specific symptoms the MD is reduced and vice versa. Low-frequency modulation seems to reflect the state of the cochlea. Compared to the generally used clinical tests for the assessment of EH like ECochG or the glycerol test, the objective method presented in this thesis is advantageous: it is fast, not straining and non-invasive. It is suitable for screening and can be used to monitor the course of disease.